SEARCH

SEARCH BY CITATION

References

  • 1
    Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mork, S.andBo, L., Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 1998. 338: 278285.
  • 2
    Trapp, B. D.and Nave, K. A., Multiple sclerosis: an immune or neurodegenerative disorder? Annu. Rev. Neurosci. 2008. 31: 247269.
  • 3
    Head, J. R. and Griffin, W. S., Functional capacity of solid tissue transplants in the brain: evidence for immunological privilege. Proc. R. Soc. Lond. B Biol. Sci. 1985. 224: 375387.
  • 4
    O'Connor, R. A., Floess, S., Huehn, J., Jones, S. A.andAnderton, S. M., Foxp3+ Treg cells in the inflamed CNS are insensitive to IL-6-driven IL-17 production Eur. J. Immunol. 2012. 42: 1174-1179.
  • 5
    McGeachy, M. J., Stephens, L. A.andAnderton, S. M., Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4 + CD25 + regulatory cells within the central nervous system. J. Immunol. 2005. 175: 30253032.
  • 6
    Zhao, J., Fett, C., Trandem, K., Fleming, E.andPerlman, S., IFN-γ- and IL-10-expressing virus epitope-specific Foxp3(+) T reg cells in the central nervous system during encephalomyelitis. J. Exp. Med. 2011. 208: 15711577.
  • 7
    Olivares-Villagómez, D., Wang, Y.andLafaille, J. J., Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J. Exp. Med. 1998. 188: 18831894.
  • 8
    Hori, S., Haury, M., Coutinho, A.andDemengeot, J., Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc. Natl. Acad. Sci. USA 2002. 99: 82138218.
  • 9
    Furtado, G. C., Olivares-Villagómez, D., Curotto de Lafaille, M. A., Wensky, A. K., Latkowski, J. A. and Lafaille, J. J., Regulatory T cells in spontaneous autoimmune encephalomyelitis. Immunol. Rev. 2001. 182: 122134.
  • 10
    Selvaraj, R. K. and Geiger, T. L., Mitigation of experimental allergic encephalomyelitis by TGF-beta induced Foxp3 +regulatory T lymphocytes through the induction of anergy and infectious tolerance. J. Immunol. 2008. 180: 28302838.
  • 11
    Montero, E., Nussbaum, G., Kaye, J. F., Perez, R., Lage, A., Ben-Nun, A. and Cohen, I. R., Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies. J. Autoimmun. 2004. 23: 17.
  • 12
    Viglietta, V., Baecher-Allan, C., Weiner, H. L. and Hafler, D. A., Loss of functional suppression by CD4+CD25 +regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 2004. 199: 971979.
  • 13
    Haas, J., Hug, A., Viehöver, A., Fritzsching, B., Falk, C. S., Filser, A., Vetter, T. et al., Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur. J. Immunol. 2005. 35: 33433352.
  • 14
    Kohm, A. P., Carpentier, P. A., Anger, H. A. and Miller, S. D., Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 2002. 169: 47124716.
  • 15
    Yang, X. O., Nurieva, R., Martinez, G. J., Kang, H. S., Chung, Y., Pappu, B. P., Shah, B. et al., Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008. 29: 4456.
  • 16
    O'Connor, R. A., Leech, M. D., Suffner, J., Hämmerling, G. J.andAnderton, S. M., Myelin-reactive, TGF-β-induced regulatory T cells can be programmed to develop Th1-like effector function but remain less proinflammatory than myelin-reactive Th1 effectors and can suppress pathogenic T cell clonal expansion in vivo. J. Immunol. 2010. 185: 72357243.
  • 17
    Zheng, S. G., Wang, J.andHorwitz, D. A., Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6. J. Immunol. 2008. 180: 71127116.
  • 18
    Xu, L., Kitani, A., Fuss, I.andStrober, W., Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J. Immunol. 2007. 178: 67256729.
  • 19
    Serada, S., Fujimoto, M., Mihara, M., Koike, N., Ohsugi, Y., Nomura, S., Yoshida, H. et al., IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 2008. 105: 90419046.
  • 20
    Maimone, D., Guazzi, G. C.andAnnunziata, P., IL-6 detection in multiple sclerosis brain. J. Neurol. Sci. 1997. 146: 5965.
  • 21
    Zhou, X., Bailey-Bucktrout, S. L., Jeker, L. T., Penaranda, C., Martínez-Llordella, M., Ashby, M., Nakayama, M.et al.,Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 2009. 10: 10001007.
  • 22
    McMahon, E. J., Bailey, S. L., Castenada, C. V., Waldner, H.andMiller, S. D., Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 2005. 11: 335339.
  • 23
    Miyao, T., Floess, S., Setoguchi, R., Luche, H., Fehling, H. J., Waldmann, H., Huehn, J.et al.,Plasticity of foxp3(+) T cells reflects promiscuous foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 2012. 36: 262275.
  • 24
    Koch, M. A., Tucker-Heard, G., Perdue, N. R., Killebrew, J. R., Urdahl, K. B.andCampbell, D. J., The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 2009. 10: 595602.
  • 25
    Segal, B. M., Dwyer, B. K. and Shevach, E. M., An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 1998. 187: 537546.
  • 26
    Jordan, J. T., Sun, W., Hussain, S. F., DeAngulo, G., Prabhu, S. S.andHeimberger, A. B., Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy. Cancer Immunol. Immunother. 2008. 57: 123131.